Cargando…
The Therapeutic Effects of Bevacizumab in Patients with Polypoidal Choroidal Vasculopathy
PURPOSE: To evaluate the efficacy and safety of intravitreal bevacizumab for polypoidal choroidal vasculopathy (PCV). METHODS: In this retrospective interventional pilot study, 12 eyes of 11 patients with active PCV were treated with intravitreal bevacizumab (1.25 mg) alone or in combination with ph...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Ophthalmological Society
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629943/ https://www.ncbi.nlm.nih.gov/pubmed/18612226 http://dx.doi.org/10.3341/kjo.2008.22.2.92 |